Nurse Practitioner · Murfreesboro, TN
NPI
1215273917
Since 2012
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3325 Shores Rd
Murfreesboro, TN, 37128
Phone (615) 867-8130
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
629 services
Medicare patients, 2024
228
Average age 71
Drug cost, 2024
$3.4M
3,375 prescriptions
Company payments, 2025
$6,841
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dana G Carter was code 99214 (office e&m - established), 307 times for 188 patients. In total Dana G Carter billed 629 services in 26 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 307 | 188 | $70.33 | $22K |
| 99213 Office E&M - Established | Office | 74 | 63 | $48.86 | $3,616 |
| 36415 Venipuncture Blood Collection | Office | 51 | 41 | $8.65 | $441 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 32 | 32 | $6.49 | $208 |
| 85025 Blood Count | Office | 26 | 20 | $7.38 | $192 |
| 82565 Clinical Chemistry | Office | 20 | 19 | $5.02 | $100 |
| 80053 Clinical Chemistry | Office | 19 | 15 | $9.87 | $188 |
| 99215 Office E&M - Established | Office | 14 | 12 | $90.12 | $1,262 |
By year: 2022 $36K for 810 services; 2023 $32K for 617 services; 2024 $31K for 629 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 51 | 41 | $8.65 | $441 |
| 85025 Blood Count | 26 | 20 | $7.38 | $192 |
| 82565 Clinical Chemistry | 20 | 19 | $5.02 | $100 |
| 80053 Clinical Chemistry | 19 | 15 | $9.87 | $188 |
Medicare prescription drug claims, 2024
In 2024, the drug Dana G Carter prescribed most often to Medicare patients was Gabapentin, with 250 prescriptions and refills. In total Dana G Carter wrote 3,375 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 250 | 375 | 62 | $3,591 |
| Donepezil Hcl Generic | 192 | 421 | 53 | $3,936 |
| Topiramate Generic | 166 | 282 | 37 | $2,604 |
| Levetiracetam Generic | 118 | 238 | 28 | $3,704 |
| Pregabalin Generic | 118 | 178 | 28 | $3,002 |
| Rizatriptan Rizatriptan Benzoate | 97 | 113 | 30 | $2,905 |
| Memantine Hcl Generic | 93 | 207 | 27 | $2,275 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 89 | 185 | 24 | $1,940 |
| Aimovig Autoinjector Erenumab-Aooe | 81 | 108 | 17 | $80K |
| Propranolol Hcl Generic | 75 | 109 | 18 | $892 |
| Oxcarbazepine Generic | 64 | 86 | Under 11 | $2,541 |
| Ubrelvy Ubrogepant | 64 | 64 | 19 | $83K |
| Nurtec Odt Rimegepant Sulfate | 63 | 67 | 17 | $131K |
| Baclofen Generic | 62 | 124 | 22 | $1,318 |
| Lamotrigine Generic | 62 | 112 | 12 | $1,177 |
Brand drugs: 630 claims; generic drugs: 2,717 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dana G Carter $6,841 ($6,841 in general payments such as food, travel and fees) from 38 companies. The largest payer was Biogen, Inc. with $3,562.
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. BIIB | 19 | $3,562 |
| Abbvie Inc. ABBV | 15 | $360 |
| EMD Serono, Inc. MRK.DE | 9 | $353 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $220 |
| Axsome Therapeutics, Inc. AXSM | 10 | $219 |
| Teva Pharmaceuticals USA, Inc. TEVA | 38 | $209 |
| Pfizer Inc. PFE | 6 | $191 |
| TG Therapeutics, Inc. TGTX | 6 | $173 |
| ANI Pharmaceuticals, Inc. ANIP | 11 | $169 |
| Alexion Pharmaceuticals, Inc. AZN | 5 | $157 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.